What is the significance of pleural fluid lactate dehydrogenase (LDH) levels exceeding two-thirds of the standard upper limit for serum in diagnosing an exudative effusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pleural fluid lactate dehydrogenase (LDH) levels exceeding two-thirds of the standard upper limit for serum is a significant criterion for diagnosing an exudative effusion, as stated in Light's criteria. This criterion is part of a set of guidelines used to differentiate exudative from transudative pleural effusions, which also include the ratio of pleural fluid to serum protein and the ratio of pleural fluid to serum LDH 1. The normal range for serum LDH can vary between laboratories, but a pleural fluid LDH level above two-thirds of the upper limit of normal for serum LDH is considered indicative of an exudative effusion. For example, if the upper limit of normal for serum LDH is 280 U/L, a pleural fluid LDH level above 186.67 U/L (two-thirds of 280 U/L) would suggest an exudative effusion.

Key Points to Consider

  • The LDH criterion is useful because it reflects increased cellular activity and breakdown in the pleural space, characteristic of exudative processes such as inflammation or malignancy.
  • An effusion is considered exudative if it meets at least one of the criteria outlined in Light's criteria.
  • While the LDH criterion is helpful, a comprehensive evaluation including clinical context and potentially other diagnostic tests is necessary for a definitive diagnosis of an exudative effusion 1.
  • Alternative tests and criteria, such as the serum-effusion albumin gradient and N-terminal pro-brain natriuretic peptide (NT-BNP) levels, can be useful in certain contexts, especially when the diagnosis is ambiguous or when specific conditions like heart failure are suspected 1.

Clinical Application

In clinical practice, the presence of a pleural fluid LDH level exceeding two-thirds of the standard upper limit for serum should prompt further investigation to determine the underlying cause of the exudative effusion. This may involve additional laboratory tests, imaging studies, and potentially invasive procedures like pleural biopsy, depending on the clinical context and suspicion of underlying disease 1.

From the Research

Significance of Pleural Fluid Lactate Dehydrogenase (LDH) Levels

  • Pleural fluid LDH levels exceeding two-thirds of the standard upper limit for serum is a significant indicator in diagnosing an exudative effusion 2, 3, 4.
  • A pleural fluid/serum LDH ratio above 0.7 indicates that the fluid is an exudate, although in about 10% of inflammatory pleural effusions due to infection or cancer this ratio is comprised between 0.5 and 0.7 2.
  • The enzyme profile of exudates is the reverse of the normal serum profile, with a decrease in isoLDH 1 and 2 and an increase in isoLDH 4 and 5, which provides little information on the origin of exudates 2.
  • A more than 30% rise in isoLDH 2 is in favor of a malignancy (mesothelioma excluded) 2.

Diagnostic Criteria

  • Light's criteria should be applied to measure the concentrations of protein and lactate dehydrogenase (LDH) in the pleural fluid and serum to determine whether a patient has a transudative or exudative pleural effusion 3, 5.
  • A pleural fluid LDH of less than two thirds of the upper limit of normal for serum LDH is one of the criteria for transudative pleural effusion 5.

Differentiating the Etiology of Pleural Effusions

  • The pleural fluid LDH-to-adenosine deaminase (ADA) ratio has been proposed as a biomarker to differentiate the etiology of pleural effusion, with a ratio <14.2 favoring tuberculous pleural effusion (TPE), a ratio >14.5 favoring parapneumonic pleural effusion (PPE), and a ratio >46.7 favoring malignant pleural effusion (MPE) 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Significance of lactate dehydrogenases in pleural effusions].

Revue de pneumologie clinique, 1986

Research

Management of pleural effusions.

Journal of the Formosan Medical Association = Taiwan yi zhi, 2000

Research

Pleural effusion: a clinical review.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1994

Related Questions

What is the significance of lactate dehydrogenase (LDH) levels in differentiating transudative and exudative pleural effusions?
What does a very high Lactate Dehydrogenase (LDH) level in pleural fluid indicate?
What is the most likely diagnosis for a patient with pleural effusion, elevated lactate dehydrogenase (LDH) ratio of 1.7, and protein ratio of 0.5?
What is the management approach for a patient with an exudative pleural effusion and high lactate dehydrogenase (LDH) levels?
What is the antimicrobial coverage of Amikacin (aminoglycoside antibiotic) versus Moxifloxacin (fluoroquinolone antibiotic) for infective exudative pleural effusion?
What type of pleural effusion is associated with pulmonary embolism (PE) and neoplastic disease?
What is the management of an 84-year-old male with cardiogenic shock and cardiorenal syndrome, currently intubated and on two vasopressors (vasoactive medications), who has acutely developed toxic megacolon?
What is the management for an 84-year-old male with cardiogenic shock and cardiorenal failure, intubated and on two vasopressors, who has acutely developed toxic megacolon?
What are the interventions for a patient experiencing emesis with a nasogastric (NG) tube in place?
What is the most likely diagnosis for a 35-year-old woman with nasal obstruction, non-purulent nasal discharge, and maxillary facial pain that has persisted for 6 weeks, with symptoms worsening initially but remaining largely unchanged since then, without taking any medications, such as antibiotics, for her symptoms, and with no significant past medical history (Past Medical History, PMH)?
Is anticoagulation therapy needed after Left Atrial Appendage (LAA) closure as part of Coronary Artery Bypass Grafting (CABG)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.